The NPIP community will help deliver life-changing breakthroughs in medical science.
The UK PET community will have unprecedented access to cutting-edge infrastructure and clinical intelligence from every research programme that joins the NPIP platform. It will transform our medical research, the quality and speed of our drug discovery and development, and diagnosis and treatment of complex multi-organ disease.
World-class research and innovation
Total-body PET scanners are capable of delivering superior quality imaging of a patient’s entire body, using low doses of radiation. This will allow many more patients to engage in clinical research. An increase in the speed at which scans can be completed will also facilitate a greater number of patient scans, enhancing the scale and impact of clinical research projects.
With a more connected network which has access to comprehensive and advanced imaging data and knowledge-sharing opportunities, NPIP will expand the scope of research opportunities into complex, multi-organ diseases and accelerate discoveries, leading to more breakthroughs for UK researchers.
More advances for UK researchers will lead to better outcomes for patients, improving the calibre of healthcare now and in the long term.
Join the Platform
Building a community of excellence
NPIP will enable the kind of collaboration in medical imaging research, the likes of which we have never seen before.
The new platform provides a unique opportunity to connect total-body PET infrastructure and intelligence for a more complete picture of patient health.
Insights from research programmes and trials across the platform will be accessible to our community. Knowledge-sharing opportunities and long-term collaboration will help us discover and develop new drugs, diagnostics and therapies, ultimately delivering better patient outcomes and increased healthcare efficiencies.
Join the Platform
Driving a global Life Science superpower
The Government’s £32m investment into NPIP sets a new standard of excellence for UK imaging research.
This presents a golden opportunity to elevate UK medical imaging research and reputation on the world stage and attract international clinical research projects to UK shores.
With a much richer picture of human health, we will be able to develop drugs and diagnostics more effectively and bring them to market quicker, so the UK can unlock new commercial opportunities in complex diseases like cancer, and cardiovascular and neurological diseases.
Collectively, we can drive forward drug discovery with renewed confidence and become a world leader in detection, diagnosis, and treatment.
Join the Platform
NPIP will allow the kind of collaboration in imaging research the likes of which the UK has never seen before. It will set a new standard of excellence for UK medical imaging research, unlocking innovative discoveries and attracting the international research community to conduct clinical trials on British soil.
Join the Platform
NPIP is a collaboration platform that enables everyone working in medical research and drug discovery to innovate across boundaries.
Join the Platform